Small molecule designed to inhibit protein aggregation associated with Alzheimer’s disease and Type II diabetes is shown to effectively reactivate a critical tumor suppressor protein inactivated in more than one-half of all human cancers.
A team of researchers at NYU Abu Dhabi has developed a biocompatible, biodegradable, and economical nanocarrier for safer and more effective delivery of anticancer drugs.
NYU Abu Dhabi science faculty and researchers are frequently featured in local and international media.
UAE researchers discover possible key to suppressing cancer tumours
Researchers in the UAE have identified compounds that may help to suppress the growth of cancerous tumours.
The National | June 30, 2021
Study finds protein aggregation inhibitor can be used to develop cancer therapies
A new study by an international team of researchers, led by NYU Abu Dhabi Associate Professor of Biology Mazin Magzoub, provides important insights into the p53 protein, a critical tumor suppressor often mutated and deactivated in cancer.
Medical Xpress | June 29, 2021
NYUAD Study Finds Protein Aggregation Inhibitor Can Be Used To Develop Cancer Therapies
Small molecule designed to inhibit protein aggregation associated with Alzheimer’s disease and Type II diabetes is shown to effectively reactivate a critical tumor suppressor protein inactivated in more than one-half of all human cancers.
Scienmag | June 28, 2021
NYUAD study finds inhibitors of protein aggregation associated with Alzheimer's disease can be used to develop Cancer Therapies
Small molecule is shown to effectively reactivate a critical tumor suppressor protein inactivated in more than one-half of all human cancers.
Zawaya | June 28, 2021
NYUAD completes research study for treatment of cancer with protein
A new study by an international team of researchers, led by NYU Abu Dhabi Associate Professor of Biology Mazin Magzoub, provides important insights into the p53 protein, a critical tumour suppressor often mutated and deactivated in cancer and a key target in the development of cancer therapeutics.
Emirates News Agency | June 28, 2021
New York Abu Dhabi completes a research study on cancer
New York University Abu Dhabi revealed in a study, promising results related to the use of protein 53 for the treatment of cancer and as one of the main solutions to suppress tumors that can be followed to treat it.
Archyde | June 28, 2021
Team of scientists develops peptides to stem Alzheimer’s
After three years of collaboration, a team of academician-scientists from the UAE, US and Sweden has designed and developed peptides believe to inhibit the progress of another group of proteins and protect the brain from the neurodegenerative Alzheimer’s Disease.
Gulf Today | September 16, 2020
A silver lining for research at a time of pandemic
Scientists are using time away from their labs to dig deeply into their data.
Nature Middle East | April 6, 2020
UAE scientists develop new targeted cancer treatment
Researchers at NYU Abu Dhabi are researching nanoparticles as a method of delivering drugs.
The National | March 15, 2020
